Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at diseases such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.
We are a global company with presence in 55 countries and with competencies and activities throughout the value chain: research, development, production, marketing and sales.
For more information please visit: www.lundbeck.com